EN PL

EMA: European Medicines Agency updates guideline on evaluation of anticancer medicines

17.01.2013
The European Medicines Agency has finalised the revision of its guideline on the evaluation of anticancer medicinal products. This revision includes, amongst other topics: the use of biomarkers as an integrated part of the development of medicines, combination therapy studies, and the choice of endpoints in confirmatory trials.